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Review Article OPEN ACCESSZusammenfassung
Hintergrund: Elektrokardiografische Verfahren stellen nach wie vor die
primär wichtigsten Methoden zur kardiologischen Diagnostik dar. Eine
Herzischämie geht mit typischen Veränderungen kardialer Biosignale
einher,dieanhandmathematischerAlgorithmenanalysiertundfürden
weiteren klinischen Pfad aufbereitet werden müssen. Die rasant
wachsende Biomedizintechnik sowie angewandte Wissenschaften be-
schäftigen sich intensiv mit neuen Ansätzen zur Auswertung kardialer
Biosignale zur Ischämiediagnostik und Risikostratifizierung.
Ziele:HauptzieldieserÜbersichtsarbeitistes,dengegenwärtigenStand
der Technik sowie neue Ansätze im Bereich elektrokardiologischer
Verfahren zur nicht-invasiven Erkennung und Risikostratifizierung von
koronarer Herzkrankheit (KHK) und Myokardischämie vorzustellen und
zu bewerten. Als Sekundärziel werden die Zukunftsperspektiven dieser
Verfahren aufgezeigt.
Methoden: Beginnend mit Expertendiskussionen während des Work-
shops„Biosignalverarbeitung“derDeutschenGesellschaftfürBiomedi-
zinische Technik (2008 in Potsdam) sowie anschließenden intensiven
RecherchenderLiteraturundDatenbankenwurdedieserReviewerstellt.
EserfolgteeineKategorisierungvonVerfahrendesStandesderTechnik
sowie ausgewählter neuer Ansätze entsprechend ihrer Einsatzgebiete
zurIschämiediagnostikundRisikostratifizierung.DieVor-undNachteile
wurden aufgezeigt und die künftigen Möglichkeiten dieser Verfahren
in der Kardiologie untersucht.
Ergebnisse: Als Stand der Technik anzusehen ist das Ruhe-EKG (insbe-
sondere geeignet für Erkennung von ST-Hebungsinfarkten) und das
Belastungs-EKG (Diagnostik von stabiler KHK). Neue belastungsfreie
Verfahren zur Erkennung von stabiler KHK sind die Kardiogoniometrie
(KGM) sowie zur Erkennung des Akuten Koronarsyndroms ohne
ST-HebungdasBodySurfacePotentialMapping,FunktionelleBildgebung
sowie die KGM. Analyse von Herzfrequenz- und Blutdruckvariabilität,
T-Wellen-AlternansundSpätpotentialendienenvorrangigderErkennung
und Stratifizierung des Risikos für letale Arrythmien bei Patienten mit
Myokardischämie oder nach durchlebtem Myokardinfarkt. Telemedizin
und technologieunterstütztes Wohnen (Ambient Assisted Living) unter-
stützen das elektrokardiologische Monitoring von Risikopatienten.
Schlussfolgerungen:EsgibtvielversprechendeAnsätzeninsbesondere
zur belastungsfreien nichtinvasiven Erkennung von KHK und Myokard-
ischämie in stabiler Phase und Akutsituation, welche in den nächsten
JahrendieStandardverfahreninderRoutinediagnostikergänzenwerden.
EbensoneueVerfahrenderRisikostratifizierungsowietelemedizinische
Techniken werden den Übergang in die Routineanwendung finden.
Schlüsselwörter: Ruhe-EKG, Ergometrie, Kardiogoniometrie, KGM,
Mapping-EKG,Herzfrequenzvariabilität,Blutdruckvariabilität,NSTE-ACS,
Koronare Herzkrankheit
Introduction
Thehistoryofclinicalelectrocardiographystartedin1887
when August Waller recorded the first electrocardiogram
onagalvanometer[1].In1902,the"FatherofElectrocar-
diography",WillemEinthoven,reproducedthewaveforms
of the electrocardiogram (ECG) [2] which he named P, Q,
R, S and T, and later added the U wave. Einthoven illus-
trated the cardiac electromagnetic current based on a
single vector (dipole) in the middle of an isosceles tri-
angle. His principle definitions are still in use today.
The first commercial electrocardiograph was manufac-
tured by the Cambridge Instrument Company in 1908. In
the 1930s, the integrated recording device, the string
galvanometer, was replaced by vacuum tube amplifiers,
which in turn gave way to modern transistors and elec-
tronics[3].Sincethen,theECGhasbecomeindispensible
in cardiology and enjoys widespread use in general
medicine.
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Huebner et al.: Electrocardiologic and related methods of non-invasive ...Figure 1: Overview of electrocardiologic and related methods including their intended applications
However,thestandard12-leadECGatrestisofteninsen-
sitive for diagnosing coronary artery disease (CAD), one
of the most frequent causes of death in industrialized
countries.Theresting12-leadECG,stillthemostcommon
method, is available in every hospital and has been used
on nearly every patient. Bicycle and treadmill electrocar-
diography was developed for cardiologists to detect
myocardial ischemia under stress conditions. The stand-
ard stress ECG attains a moderate accuracy for CAD and
myocardial ischemia, but is of feasibility in screening
tests, especially in asymptomatic patients. The 24-hour
Holter ECG is used for the primary diagnosis of cardiac
arrhythmias. In patients with acute coronary syndrome
(ACS), only ST-elevation myocardial infarctions (STEMI)
are unequivocally visible on the standard ECG. Non-ST-
elevation myocardial infarction (NSTEMI) and unstable
anginapectoris(UAP)areidentifiablewithalowsensitivity
only. Enhanced ECG analysis tools are relevant for
ischemia diagnosis and risk stratification, but have not
become routine diagnostics yet either.
About15%ofpeopledieofsuddencardiacdeathcaused
by underlying arrhythmic events [4]. Approximately 50%
of all CAD deaths are sudden and unexpected, occurring
within 1 hour after a change in cardiac status [5]. Since
the introduction of intracardiac electrocardiography by
Scherlagin1969[6]newtherapeuticmethodsforcertain
arrhythmia, such as radiofrequency ablation of reentry
tachycardia or of atrial fibrillation, have been developed
[7], [8]. Here, a challenge for future electrocardiography
istodefinescreeningparameterstopredicttheindividual
risk of arrhythmic events.
Objectives and methods
The aim of this review is to present the state of the art in
electrocardiologic methods for non-invasive detection
and risk stratification in coronary artery disease (CAD)
with emphasis on myocardial ischemia and its sequelae,
secondarily, to explore the future perspectives of these
methods. In follow-up to the Expert Discussion as part of
the 2008 Workshop on Biosignal Analysis held by the
German Society of Biomedical Engineering in Potsdam,
Germany [9], we initiated our search of the pertinent lit-
eratureanddatabasesandcompiledtheresultsintothis
review. Based on the compiled data, we established and
then categorized a selection of state-of-the-art methods
in and new approaches to the detection and risk stratifi-
cationofmyocardialischemia.Finally,wedeterminedthe
pros and cons of each method and explored their future
potentials for cardiology. The focus was on trends in non-
invasive electrocardiography for cardiac ischemia from
theperspectiveofbiosignalanalysisandappliedscience.
Results
An overview of our categorization of the methods into
main categories is presented in Figure 1, Table 1 and
Table 2. The following describes our analysis of each
method by category.
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detectionofmyocardialischemiaandCADinstableandacute
phases
Table 2: Selected electrocardiography-based methods for
arrhythmic risk detection and stratification for ACD
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Resting electrocardiography
WhilerestingECGmayrevealsignsofpreviousinfarctions
anddiagnosticallyrelevantinformationinACS,itisinferior
for diagnosing CAD in the non-acute (chronic) stage.
Typical signs provided by the 12-lead ECG for chronic
ischemic injury after myocardial infarction, such as
Q-wave, T-wave polarity and R-reduction, are empirically
analyzed by sight. Such indicators could be absent espe-
cially after tiny, non Q-wave myocardial infarction [10],
[11]. A resting ECG might miss the typical sign of
ischemia,i.e.ST-segmentdepression,onlydemonstrable
under exercise conditions. Myocardial ischemia is poten-
tially a reversible functional alteration and mainly alters
the repolarization in the affected areas. Primarily, the
subendocardialmyocardiumisaffectedwiththeST-vector
pointing from epicardial to endocardial, resulting in an
ST-depression in the surface ECG. In transmural injury,
the direction of the ST-vectors reverses from endocardial
to epicardial and an ST-elevation occurs. ECG changes
in acute ischemia are best visualized in limb leads I, II
and precordial leads V4–6, which represent the most
myocardial mass of the anterior and apical area of the
leftventricle.ThecourseoftheSTdepressionishorizontal
or descending and can be accompanied by a T-wave
flatteningorapreterminalnegativeT-wave.Lesscommon
manifestations of acute coronary insufficiency are tem-
porary banking of the T wave or U wave inversion [12].
The 12-lead ECG recorded at rest is central part to the
diagnosis of ACS. Figure 2 illustrates different infarc-
tion/electrocardiographicphasesrecordedinSTEMI[13].
A STEMI is easily diagnosed when the ECG shows ST-
elevations of ≥0.1 mV in at least two sequential limb
leads or ≥0.2 mV in at least two sequential precordial
leads. In acute STEMI, the 12-lead resting ECG is the
leading diagnostic tool for emergencies [14] and life-
threatening situations where the indication for invasive
angiography needs to be rendered rapidly. Patients with
acute chest pain lasting longer that 20 min and a normal
resting ECG without ST-elevation can be presumed to
haveanNSTEacutecoronarysyndrome(NSTE-ASC,UAP).
ECG's sensitivity for detecting true NST-ASC is very low
(~20%)[15].Additionallaboratoryworkups,liketheserum
troponin T test can help detect myocardial necrosis with
suspected underlying coronary occlusion. The troponin T
level increases about 4 to 6 hours after the first myocar-
dial damage. UAP should be distinguished from early
myocardialinfarctionasquicklyaspossible–adiagnosis
impacting emergency treatment and prognosis. In all
patients at high risk for life-threatening arrhythmias,
continuous ECG monitoring and regular analyses of the
ST-segment, especially any elevations are imperative
[16].
Different kinds of arrhythmias, particularly ischemia-as-
sociatedventriculararrhythmiascouldindicatemyocardial
ischemia and be critical and live threatening. New con-
duction disorders such as left bundle branch blocks are
suspicious for acute myocardial ischemia. Such arrhyth-
mias and conduction disorders are often initially diag-
nosedbyrestingECGandthenweighedintothedifferen-
tial diagnosis along with clinical signs andlaboratory re-
sults for acute myocardial infarction. Current procedure
can be enhanced by advanced diagnostic methods and
intensive caremonitoring [17].
Exercise electrocardiography
The 2002 AHA/ACC Guidelines on exercise testing [11]
define two main groups for whom exercise testing is in-
dicated 1) patients with suspected obstructive CAD and
2) patients with a documented myocardial infarction or
prior coronary angiography demonstrating significant
disease or verified CAD. Figure 3 shows typical
pathological and physiological changes.
Knowledge of a patient's pre-test probability is recom-
mendedandrequired[18].AccordingtoBayes’theorem,
theprobabilityofapatienthavingthediseaseafteratest
has been carried out is the product of the disease prob-
ability before the test and the probability that the test
was accurate. A meta-analysis of 147 consecutively
published reports involving 24,074 patients undergoing
both coronary angiography and exercise testing revealed
a wide variability in sensitivity and specificity for exercise
ECG[19]Thesestudiesdemonstratedameansensitivity
of 67% and a mean specificity of 72% in patients without
previous MIs.
A special type of ECG uses three to six additional leads.
Small studies have shown that a 15-lead stress ECG can
improvesensitivitycomparedtothe12standardchannel
recordings (from 52% to 89% in one-vessel diseases,
from 71% to 94% in two-vessel diseases, and from 83%
to 95% in three-vessel diseases). The additional leads of
the15-to-18-channelECGalsoallowimprovedidentifica-
tion and risk stratification particularly of right ventricular
ischemia and infarction [20].
The fact that many patients are not able to perform ad-
equate bicycle exercise testing or do not reach the target
heart rate is the main disadvantage of exercise ECG. In
one study investigating the prognostic significance of ex-
ercisetestingon6,296patientstreatedwiththrombolytic
agents secondary to myocardial infarction, Villella et al.
showed that the exercise ECG examination was contrain-
dicated in 62.5% [21]. Patients unable to exercise be-
causeofphysicallimitationsthataffectexercisecapacity
(e.g. arthritis, amputations, severe peripheral vascular
disease, severe chronic obstructive pulmonary disease,
orgeneraldebility)shouldundergopharmacologicalstress
testing in combination with imaging. In this context,
Figure4providesanoverviewofthecompiledguidelines.
5/19 GMS German Medical Science 2010, Vol. 8, ISSN 1612-3174
Huebner et al.: Electrocardiologic and related methods of non-invasive ...Figure 2: Electrocardiographic phases of STEMI adapted from the Pschyrembel database [13]
Figure 3: Nonpathologic (top) and pathologic (bottom) exercise ECG reactions adapted from Pschyrembel database [13]
Enhanced electrocardiographic
approaches
Signal averaged electrocardiography
Signal-averaged ECG was introduced in the 1970s and
primarilyfocusesonHisbundlerecordingsanddetection
of patients at high risk of sudden cardiac death after
myocardial infarction and is shown in Figure 5 [22].
Microvolt level ventricular late potentials (VLP) are fre-
quently detected in patients with ventricular tachycardia
(VT),especiallyaftermyocardialinfarction.Thelatepoten-
tials correlate with delayed and disorganized activation
insmallareasofthemyocardium.Theprognosticsignific-
ance was reviewed in 1987 [23] in 778 patients; VT or
suddencardiacdeath(SCD)increasesinabnormalsignal
averaged ECG from 0.8–3.5% to 16.7–28.9%. VLP as-
sessment offers a practical and low-cost tool for the
clinical cardiologist to recognize the possible electro-
physiological substrate underlying life-threatening
ventricular arrhythmias [24]. However, one of the most
important problems in VLP analysis is the high number
of false positive results. In combination with heart rate
variability (HRV) analysis VLP could enhance the risk
stratification [25].
The main task in recording low-level bioelectrical signals
from the heart is to reduce extraneous noise. By signal
averaging the level of noise that contaminates the ECG
can be decreased. The sources of noise are skeletal
muscle activity, electrodes and electrical noise from
amplifiers.Musclenoisecannotbeeliminatedbyfiltering,
becauseitsfrequencycontentissimilartohigh-frequency
(over 25 Hz) cardiac potentials. Averaging 100 cycles will
reduce noise 10fold [26]. However, some problems of
the applied sequential averaging techniques remain as
e.g.themissingbutpresupposedstationarityofbiosignals
and the dependency on time stable events leading to an
at least smoothing effect in potentials with beat-to-beat
varyingdistancetothetriggerpoint(Rpeak).Indicesfrom
time domain and frequency domain were developed to
characterizeVLPs.LateronVLPscouldbeextractedfrom
magnetocardiogramandfrom24-hourHolterrecordings.
Body surface potential mapping
MultichannelECGprovidescomprehensive3-dimensional
data of the electrical currents from the heart on the body
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considering electrocardiologic and related methods concerning acute and stable ischemic situations and risk stratification
Figure 5: Example for high-resolution ECG
Top: Sum vector, Bottom: 3 dimensional frequency spectrum; Left: Patient with late potentials at high risk for sudden cardiac
death with prolonged QRS in sum vector (low-amplitude electrical signal which occurs in the terminal QRS complex or within the
STsegment)andenhancedhighfrequencycomponentsinthespectrum.Right:Patientwithlowriskprofileandnolatepotentials,
see also [22].
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Huebner et al.: Electrocardiologic and related methods of non-invasive ...Figure 6: Corrected body surface potential map at the time point 260 ms (cursor position)
Eleven amplitude levels from S11 to S1 in mV are shown (V - front view; H - back of the sphere and the heart). With the kind
permission of [28].
surfaceandcangiveaccesstohigh-resolutionspatiotem-
poral analyses in patients with suspected CAD. Body
surface potential mapping (BSPM) (Figure 6) uses 64 or
moreelectrodes(asmanyas120)torecordandmeasure
electrocardiac activity over a much larger portion of the
torso than the traditional 12 lead-ECG [27], [28].
BSPMfeaturesdifferentapproachesforregisteringdiffer-
ent cardiac conditions and has been used for diagnosing
old inferior myocardial infarctions, localizing the bypass
pathway in Wolff-Parkinson-White syndrome and recog-
nizing ventricular hypertrophy. BSPM may show potential
inascertainingthelocation,size,andseverityofinfarcted
areas in acute myocardial infarction and identify the ef-
fects of interventions to reduce infarct size [29], [30],
[31].MoreresearchintothevalueofBSPMindiagnosing
ACS is needed [32], [33].
Alternative lead systems must be compared to standard
12-lead ECG in well-designed clinical studies to achieve
clinicalacceptance.While,LefebvreandHoekstra(2007)
demonstrated the usefulness of BSPM in the emergency
department in their large-scale OCCULT-MI trial [34], this
new technology is limited by the complexity of records
and analyses requiring up to 120 leads, overly sophisti-
catedinstrumentationanddedicatedpersonnel.Theuse
ofalargernumberofleadsinBSPMmayprovideclinically
relevantinformationforspecificpatientsgroups.Ongoing
researchcontinuesonBSPM,butitsclinicaleffectiveness
has not been established in larger studies.
Vectorcardiography and
cardiogoniometry
Einthoven'sNobelprize-winningillustrationofthecardiac
electromagnetic current was based on a single vector
(dipole) in the middle of an isosceles triangle. The elec-
trical and geometrical requirements for his hypothesis
were a spherical body surface with a homogeneous
volume conductor and only one source for the dipole in
the middle.
Because a single human heart cycle does not quantita-
tively fulfill these conditions, a method for analyzing 3D
electrocardiography data, known as vectorcardiography
(VCG) was developed the late 1930s and many different
VCG lead methods advanced since then [35], [36], [37].
The most common is the 7-lead method developed by
Frank [38]. VCG was especially popular from the 1950s
to 1980s. A widely published method, it was mainly used
for ischemia diagnosis and has proved its potential in
principle [39], [40], [41], [42], [43], [44], [45]. For ex-
ample, Mengden et al. retrospectively showed that VCG
using 5 parameters for discriminant analysis has a
sensitivityof77.8%andaspecificityof78.4%indiagnos-
ing a coronary condition compared to coronary an-
giography [39]. Difficult to interpret, VCG never became
established as a routine method and, despite new ap-
proaches for use in ischemia [46], has lost importance.
Rubulis has summarized the results of VCG studies and
publications from the Karolinska Institute, Stockholm on
the analysis of T-vectors and T-loop morphology in
myocardial ischemia. He showed significant differences
in ventricular repolarization in patients with CAD [47]
compared to the healthy control group, even in the ab-
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the T-loop and its shape and roundness significantly
differed between CAD patients and healthy controls.
Mostly, acute ischemia consistently reduced T-loop
planarity and increased its roundness and area under T-
loop [47]. Rubulis further investigated the relationship
between the size and location of myocardium at risk and
the ventricular repolarization response during ischemia
(duringelectivePCIandTc-99m-sestamibiadministration).
Ventricular repolarization measures during maximum
ischemia were compared with baseline measurements
and the changes were related to the myocardium at risk
andtheoccludedartery.Hefoundsignificantcorrelations
between the size of myocardium at risk and ST-segment
alterations and changes of T-loop planarity, shape and
roundness.Inalongitudinalcohortstudy,Rubulisfollowed
187 CAD patients for 8±1 years. Cardiovascular death
wasindependentlypredictedbyaprolongedQRSduration
and a widened QRS-T angle (spatial angle between max-
imumvectorsofR-loopandT-loop).Myocardialinfarction
was most consistently predicted by increased T-loop
planarity [46].
Cardiogoniometry
Cardiogoniometry (CGM, Figure 7) is a spatiotemporal
vectorcardiographic advancement of the VCG principle.
CGM was introduced by Sanz [48] and further developed
and tested in patients with stable CAD by Schuepbach
[49].CGMusesthreebipolarelectrocardiographicderiva-
tives and automatically analyses a 12-second recording
taken at rest using a programmed score. The original
scoring system used in the retrospective cohort yielded
asensitivityof73%andaspecificityof87%.Inaprospect-
ive cohort, CGM showed a sensitivity of 64% and spe-
cificity 82% [50].
For global CAD detection by CGM, Huebner et al. system-
aticallydevelopedastenosis-specificparameterset[51].
A total of 658 study patients, matched for age, BMI, and
gender, were angiographically assigned to 8 stenosis-
specific CAD categories or to the controls. One CGM
parameterpossessingsignificance(P<0.05)andthebest
diagnostic accuracy was matched to one CAD category.
TheareaundertheROCcurvewas.80(globalCADversus
controls). A set containing 8 stenosis-specific CGM par-
ametersdescribedvariabilityofRvectorsandR-Tangles,
spatial position and potential distribution of R/T vectors,
and ST/T segment alterations.
Further prospective validation of these algorithms is on-
going to evaluate the impact of CGM for early discrimina-
tion of non-ST-segment elevation ACSs (NSTE-ACS). The
initial results of the prospective multicenter trial
CGM@ACS was presented by Toelg et al. (2010). CGM’s
sensitivity to detect NSTE-ACS patients was 73%. These
preliminaryresultsindicatethatCGMhasahighpotential
for detecting patients with NSTE-ACS probably earlier
than troponin levels [52].
Figure 7: Principles of cardiogoniometry
A) Four electrodes are placed at four points on the patient’s
thorax as follows: Point 1 (green) at point V4 of Wilson, i.e. in
the5
thintercostalspaceinthemid-clavicularline;point2(white)
sagittal to electrode 1 on the back (point V8 of Wilson); point 3
(yellow) is located perpendicularly above electrode 1 at 0.7
times the distance between points 1 and 2; point 4 (red) is
placed to the right of point 3 at the same distance as between
points1and3.Theleadsaredefinedasfollows:4-2D(dorsal),
4-1 A (anterior), 2-1 I (inferior), 4-3 Ho (horizontal), 3-1 Ve
(vertical). B) Points 4-2-1 define the oblique sagittal plane OSP
(red); points 4-3-1 define the frontal plane (yellow). The third
plane (blue) is orthogonal to the two other planes and contains
point 3; it is the sagittal plane perpendicular to the OSP.
Projection x is oriented in an antero-dorsal direction and lies in
the OSP and the sagittal plane perpendicular to the OSP.
Projection y is oriented in a baso-apical direction and lies in the
OSP(4-2-1)andthefrontalplane(4-3-1).Projectionzisoriented
in a supero-inferior direction relative to the OSP and lies in the
frontalplane(4-3-1)andthesagittalplaneperpendiculartothe
OSP. C) Vector loops from projections x, y and z can be
calculated within a Cartesian coordinate system. Figure shows
R-Loops (blue) and T-loops (green) of 12 heart cycles and
maximum vectors of both (red), calculated on median cycle.
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electrocardiographic methods in ACS, prognostic evalu-
ationandriskstratificationhavenotbeenproveninlarger
studies. Recent smaller VCG studies have confirmed in
principle the value of these methods in diagnosing CAD
andacuteischemiaandalsoinriskstratificationforSCD.
Analysis of cardiovascular variability –
risk stratification methods
Heartratevariabilityandheartrateturbulence
The clinical importance of autonomic control became
apparent in the late 1980s, when heart rate variability
(HRV) was confirmed to be strong and independent pre-
dictorofmortalityafteracutemyocardialinfarction.There
was a significant relationship between the autonomic
nervous system and cardiovascular mortality, including
sudden cardiac death. Thanks to the availability of high
frequency 24-h electrocardiographic Holter recorders,
HRV can potentially provide additional valuable insight
into physiological and pathological conditions and risk
stratificationindifferentcardiacdiseases[53],[54],[55].
There are many commercial available automated HRV
measurement devices utilizing variety of methods [56],
[57],[58],providingcardiologistswithaseeminglysimple
tool for both research and clinical studies.
In 1996, a Task Force of the European Society of Cardi-
ology and the North American Society of Pacing and
Electrophysiology defined time and frequency domain
parametersfortheevaluationoftheautonomicregulation
[59]. The simplest parameters to perform are the time
domain measures. With these methods either the heart
rateatanypointintimeortheintervalsbetweensuccess-
ive normal complexes are determined. Various spectral
methods[59]fortheanalysisofthetachogramhavebeen
applied since the late 1960s. Power spectral density
(PSD) analysis provides the basic information of how
power (i.e. variance) is distributed as a function of fre-
quency.
The Framingham study included HRV data from 2501
patients initially free of coronary artery disease or coron-
ary heart failure, showing that a reduced HRV predicted
an increased risk for subsequent cardiac events [60]. In
another study, the ARIC (Atherosclerosis Risk in Com-
munity) study on 2252 patients, a decrease in the high
frequency band (HF power) was a significant predictor
for an ischemic event [61].
In a study including 715 patients two weeks after
myocardial infarction, Bigger et al. tested whether short-
term power spectral measures of RR variability predicts
all-cause mortality or arrhythmic death. Here, power
spectral measures of RR variability proved excellent pre-
dictorsofall-cause,cardiac,andarrhythmicmortalityand
suddendeath.Patientswithlowvalueswere2to4times
as likely to die over an average follow-up of 31 months
as were patients with high values [62]. The slope of the
power-law relationship predicts death in post-infarction
patients [63]. According to the authors' observations, a
steep power-law slope was a powerful predictor of all-
cause mortality or arrhythmic death and predicted these
outcomes better than the traditional HRV parameters of
the frequency domain.
A multivariate approach [64] yielded the best prediction
forall-causemortalityandsuddenarrhythmicdeath.This
study enrolled 572 survivors of acute myocardial infarc-
tion.Duringfollow-up,43patientsdied(all-causemortal-
ity),13ofthemdiedfromventriculartachycardia/ventricu-
larfibrillation,14fromsuddenarrhythmicdeath,22from
sudden death and 34 from cardiac death. A combination
of four HRV parameters from all domains (time and fre-
quency domain, symbolic dynamics) in this multivariate
approach improved the diagnostic precision more than
twofold. Other post-infarction studies have shown that a
reduced short-term scaling exponent is a more powerful
predictor of mortality than the traditional measurements
of HRV [65], [66].
More recently, fractal heart rate variability has been
shown to retain its prognostic power even for patients
taking beta-blockers after an acute myocardial infarction
[67].IntheDIAMONDstudy,areductionintheshort-term
fractal exponent was the most powerful predictor of all-
cause mortality in 446 survivors of acute myocardial in-
farction. The exponent predicted both arrhythmic and
nonarrhythmic cardiac death [68].
In 1999, the analysis of the heart rate turbulence (HRT),
which describes the fluctuations of the RR interval after
ventricular premature beats, was introduced. HRT is
usually described by two parameters, the turbulence on-
set and the turbulence slope. The turbulence onset de-
scribesthedifferencebetweenthemeanofthetwosinus
RR intervals before and the first two sinus RR intervals
after the ventricular premature depolarization divided by
the mean of the last two sinus RR intervals before the
ventricular premature depolarization. The turbulence
slope is defined as the highest slope of the regression
lineoveranyofthefivesuccessivesinusbeatRRintervals
during first 20 sinus beat RR intervals after a ventricular
premature depolarization [69].
It is expected that the intensified investigation of interac-
tions and couplings between heart rate and respiration
andbetweenheartrateandbloodpressure,respectively,
withavarietyofmethodsparticularfromnonlineardynam-
ics will not only increase our knowledge about the com-
plexautonomicregulation[70],[71],[72],[73],[74],[75]
but will lead us to an enhanced diagnostics and therapy.
In addition to the well-accepted application in cardiology,
HRV has also drawn attention in other important applica-
tion fields as e.g. intensive care medicine. Werdan et al.
showed that, in patients with multiorgan dysfunction
syndrome,adrasticreductioninHRVwasobserved,both
the sympathetic as well as the vagal component, correl-
ating with an unfavorable prognosis [76]. They further
found that endotoxin can interfere with the pacemaker
currentandsympathetictone,therebyalteringheartrate
variability and bridging autonomous nervous system and
inflammation. Furthermore, a reduction of HRV is seen
with increasing age [77], indicating somewhat of cardiac
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see also [83]
ageing [78]. Finally HRV exhibits a considerable gender
dependency [79].
Blood pressure variability
While most studies on autonomic control are performed
by HRV analysis, spontaneous blood pressure variability
(BPV) is used increasingly as additional and complemen-
tary ‘window’ into cardiovascular control mechanisms.
Beat-to-beat registration of systolic and diastolic blood
pressurehasbeenevaluatedindifferentcardiacdiseases
[80], [81]. There is a significant correlation to baroreflex
sensitivityinpatientswithhypertensionindependentlyof
age and systolic blood pressure and also data about the
increase of BPV in early stage of hypertension. Besides
ischemic cardiomyopathy, BPV analysis has prognostic
valueinhypertensiveheartdiseaseanddilatedcardiomy-
opathy, reflecting the clinical relevance of BPV for auto-
nomic control physiology and cardiac risk stratification
[81], [82]. While HRV did not contribute to risk stratifica-
tion in patients with dilated cardiomyopathy (DCM), BPV
analysisyieldedsignificantparameters.Nonlineardynam-
ics indices (primary developed for HRV analysis and
adaptedtoBPVanalysis)asShortTermSymbolicDynam-
ics (STSD) and Poincare Plot analysis (PPA, Figure 8) dif-
ferentiated best between low and high risks (maximum
sensitivity: 90%, specificity: 90%) [83].
Microvolt T-wave alternans
Patients who survive a myocardial infarction, particularly
thosewithresidualleftventriculardysfunction,areatrisk
of serious arrhythmic events and SCD. This risk is often
assessed as a sustained, microvolt phenomenon with
exercise [84]. Microvolt T-wave alternans (MTWA) test is
anovelnon-invasivemethodforassessingrepolarization
alternans and is useful for estimating an individual's risk
for SCD. The test is comparable to a stress ECG and car-
ried out on a treadmill. MTWA measures an extremely
subtle beat-to-beat fluctuation in the T-wave segment of
a patient's heartbeat that is a specific marker of ar-
rhythmic vulnerability and the likelihood of a sudden
cardiac death.
Repolarizationalternansisasensitivemarkerofunderly-
ing abnormalities in electrical structure. A negative exer-
ciseMTWAidentifiespatientsatlowriskofseriousevents,
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dictiveaccuracy.Ameta-analysisincorporating19studies
(2,608subjects)foundanoverallpositivepredictivevalue
of MTWA for arrhythmic events to be 19.3%, a negative
predictive value of 97.2%, and the univariate relative risk
for an arrhythmic event of 3.77. The authors concluded
that MTWA testing has great value for predicting
ventriculartachyarrhythmicevents,butisalsoverylimited
in its use because the predictive value of MTWA varied
significantly depending on the population studied [85].
The REFINE study compared the MTWA test to HRV
parameters and the cardiac functional marker of left
ventricular ejection fraction after myocardial infarction.
So far, only the combination of abnormal MTWA plus im-
paired autonomic tone has reliably predicted the risk of
sudden cardiac death after myocardial infarction as the
secondary outcomes of all-cause mortality and fatal or
nonfatal cardiac arrest [86].
The ongoing prospective multicentre ABCD study is com-
paring MTWA to invasive electrophysiology as the "gold
standard of risk stratification" for use in guiding prophy-
lacticimplantablecardioverterdefibrillator(ICD)insertion.
Of 566 patients followed for a median of 1.9 years, 39
(7.5%) met the primary endpoint of appropriate ICD dis-
charge or SCD within 1 year. Primary results showed that
MTWA achieved 1-year positive (9%) and negative (95%)
predictive values that were comparable to an electro-
physiological study (11% and 95%, respectively) [87].
Electrocardiographyincombinationwith
imagingtechniques(functionalimaging)
The great potential of functional imaging (electrocardio-
graphy combined with imaging techniques), also known
as cardiac hybrid imaging, allows a comprehensive
evaluationofcoronaryarterydiseasebyyieldingmorpho-
logical and functional information. The SPECT/CT and
PET/CT hybrid are examples of methods that noninva-
sivelyprovideuniqueinformationthatimprovesdiagnostic
assessment and risk stratification and also impacts de-
cision-making for revascularization in patients with
coronary artery disease.
Functional imaging is also of relevance for noninvasively
visualizingcardiacelectricalactivitythroughoutthethree
dimensional myocardium. Therefore, the combination of
a spatiotemporal reconstruction technique with an ima-
ging method will result in an electrocardiographic func-
tionalimaging.Theclinicalrelevancewasshownininvas-
ive mapping systems: the inclusion of a thoracic volume
san – which was performed before the investigation –
can be used for a better guidance for interventions like
catheter ablation of arrhythmias.
Non-invasive functional imaging provides insights to
electrocardiographic alterations in myocardial ischemic
or infracted areas. To solve the inverse problem of elec-
trocardiography,acomputermodeloftheindividualheart
of a patient based on a 3D-MRI dataset can be used.
Sourcedistributionsinsidetheheartaresimulatedusing
a cellular automaton. With a finite element method, the
correspondingBSPMiscalculated.Characteristicparam-
eters like duration and amplitude of transmembrane po-
tential or velocity of propagation are optimized for select-
ed tissue classes or regions in the heart to fit simulated
data to the measured data. This way the source distribu-
tion and its time course of an individual patient can be
reconstructed [88].
He and Wu developed novel electrocardiographic tomo-
graphy techniques to image cardiac current density dis-
tributionswithinthemyocardium[89].Arealisticgeometry
inhomogeneousheart-torsomodelbasedontomographic
imaging was used to localize the site of origin of cardiac
activation, show the cardiac activation sequence and
image the transmembrane potential distribution within
the 3D anisotropic myocardium. The spatio-temporal co-
herence of ventricular excitation processes has been
utilized to derive the activation time from the estimated
time course of equivalent current density defined as the
spatial gradient of transmembrane potential.
Monitoring
Telemedicine
Telemedicine is a rapidly developing application of mod-
ern communications and information technologies to
deliver clinical data to users, for example, from general
practitioners to hospitals. Care at a distance is an old
practice that was often conducted by post or radio.
Nowadays, this medical information is transferred by
telephone, the Internet or other networks. Two types of
homecare telemedicine are in use [90]: 1) monitoring of
vitalbiosignalscombinedwithafeedbackand2)teaching
approach(homenursecall).MobiledevicestransferECG
and other vital data to a telemetry platform on demand
and on a daily basis. Telemetry platforms are accessible
viaamedicalbackupduring24hours.Dataareanalyzed
online and telephone visits will follow immediately if vital
parameters are out of normal range [91].
Mobile device transfer ECG can be useful in early detec-
tion of ACS and silent ischemia, especially after work
hours and on weekends, and could also pre-categorize
patientsintoSTEMIandothercoronarysyndromesduring
the pre-hospital phase [92]. Data on telemedicine show
feasibility,costeffectivenessandreductionofhospitaliza-
tion rates and time in cardiac patients with chronic heart
failure [93]. Fewer resources for inpatient care of an in-
creasingly older population require new approaches for
ambulatory disease management, particularly in the
chronically ill. Home care telemedicine may improve the
ambulatory care of elderly patients with chronic cardiac
diseases and support the health systems.
Ambient Assisted Living
Ambient Assisted Living (AAL) is a technology and innov-
ation funding program of European countries, supported
by the European Commission [94] aimed to extend the
time the elderly can live at home by increasing their
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ities.Vitalsignsmonitoringandfalldetectionindomestic
and outdoor environments is important for preserving
independence. This requires the monitoring of data from
accelerometers in addition to the usual vital signs espe-
cially outside the home. The high incidence of CAD and
myocardial infarction in the elderly warrant the inclusion
of ischemia electrocardiography in the AAL concepts.
Earlydiagnosisandtherapyofmyocardialinfarctioncould
prevent heart failure and disability. In cardiac patients
with CAD, a multichannel ambulatory ECG is preferable
to a one-channel system for excluding acute STEMI in
suspected acute ischemia. Myocardial infarction and
cardiac arrhythmias are the main cardiac diseases tar-
geted for AAL monitoring.
A new telemonitoring project called CAALYX (Complete
AmbientAssistedLivingExperiment)wassetuptomonitor
detaileddataabouttheuser’smedicalstatusandlocation
[95]. Other projects have investigated the feasibility of
passive wireless in-home monitoring systems that trans-
mit data from biological variables and everyday habits
(bodyposition,movements)toacentralmonitoringstation
for use in the telemedicine activities of the Health
Telematic Network for home help only [96]. Continuous
mobileECGsystemswithpercutaneousconnectors,leads
andcablespresentobviousdisadvantageslikerestricting
mobility and causing skin irritations. Persons with more
severe cognitive impairment are less likely to accept
mobile monitoring systems. This is a relevant limitation
forsystemsingeriatricmedicine[97].Modernbiomedical
solutions use implanted systems for the wireless in-vivo
monitoring of physiological parameters [98]. Another
approach includes alternative electrode systems techno-
logies, e.g. textile integrated solutions inserted in body
area networks systems. Improved microsystems techno-
logy will substantially increase the range of implantable
biomedical devices and body area networks related
solutions in the coming years [99].
Discussion and conclusions
Thisreviewhasanalyzedthestateoftheartofelectrocar-
diologic methods and categorized them according their
intended applications (Figure 1, Table 1 and Table 2).
Now, we will discuss their current relevance and future
potentials, weighing the advantages and disadvantages.
Resting electrocardiologic methods
Except for diagnosing STEMI, state-of-the art electrocar-
diography does not provide enough data to detect stable
CADandacutemyocardialischemiaintherestingpatient.
Myocardialischemiacausedbycoronarystenosis,poten-
tially reversible at rest [100], is primarily detectable by
exercise ECG.
In a vanguard study [50], the use of cardiogoniometry at
rest – as an example for a spatiotemporal vectorial ECG
approach – compared to standard exercise ECG had
shownpromisingresultsforthediagnosisofCAD.Further
studieswithlargerpopulations,especiallywithreference
standardsdisplayingmyocardialperfusionarenecessary
withregardtobothafurtherprospectivevalidationofthe
method for the diagnosis of stable CAD and the develop-
ment of methods for diagnoses in the acute phase [25].
The reasons why asymptomatic or stable CAD may be
detected by electrophysiological investigations at rest,
althoughthecoronarystenosesmaynotbehemodynam-
ically relevant at the examination due to the heart flow
reserve, still need to be explained. In this regard, the
pathophysiological mechanisms that theoretically lead
to stunning, hibernating myocardium and reversible
mechanical dysfunction in patients with coronary artery
disease summarized by Mazzadin et al. in their review
may provide a hypothetical explanation for the changes
inenhancedelectrocardiographicparameters[101].Even
in the absence of frank (symptomatic) myocardial
ischemia, atherosclerotic coronaries can cause electro-
physiological changes.
Promising new electrocardiographic approaches using
high-resolution registration technology, signal averaging
and the use of multiple channels can detect alterations
in current density distribution caused by myocardial
ischemia and may also detect discrete myocardial injury
at rest. These methods are classified as new diagnostic
tools for diagnosing CAD.
Risk stratification methods
Themethodsmostsuitableforestablishingwhichpatients
are at risk for sudden cardiac death (lethal arrhythmic
events)whorequiretreatment(Figure1)areECG(includ-
ing Holter ECG/exercise ECG), HRV, HRT, BPV, MTWA and
signal averaged electrocardiography.
In general, new parameters for risk stratification need to
beintroducedtobetterrenderindicationsforimplantable
cardioverterdefibrillators(ICD)[102].Thenumberneeded
to treat to save one life with an ICD is above 10 patients
over 2-year period, while an ICD was projected to add
1–3 QALY, but costs between $70,000 and $100,000.
These recommendations for ICD in primary prevention of
sudden cardiac death in ischemic and non-ischemic car-
diomyopathy patients are primarily based on ejection
fraction.
AllnonlinearmethodsofHRVassessqualitativeproperties
rather than the magnitude of the signal and have been
shown to deliver incremental and additional prognostic
information under various pathophysiological conditions
compared with the conventional measures of heart rate
fluctuations. These novel approaches can also comple-
menttraditionaltime-andfrequency-domainanalysesof
cardiovascular variabilities [103]. However, for complex
analyses of cardiovascular oscillations, a multivariate
approach(combiningparametersfromdifferentdomains)
is essential [104].
Nowadays, alternans analysis, subsumed under MTWA,
is one of the methods with the highest level of evidence
for stratifying risks ranging from ventricular tachyar-
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trates on the spatial and temporal heterogeneity of the
repolarization phase.
Functional imaging
3D electrocardiographic methods seem to be one of the
more challenging tasks for detecting patients at the risk
of sudden cardiac events. Spatiotemporal registration
canidentifyfocalirregularitiesincurrentdensitydistribu-
tion caused by local myocardial ischemia or myocardial
scars.Theadvantagesoflowsignal-to-noiseratiobysignal
averaged registration modus of the electric field could
be used with high-resolution registration techniques. Ad-
vances in computation technology could provide fast
analyses of such complex data sets.
The analyses of the spatiotemporal coherence of
ventricularexcitationprocessesarehighlypromisingand
may lead to the establishment of a three dimensional
cardiacelectricalimagingtechnologyforfunctionalcardi-
ac imaging for better indication and aiding of invasive
cardiac applications.
In the context of ischemia, functional imaging could also
be the basis for a future non invasive stress testing
providingfocalischemiadetection.Thecombinationwith
pharmacological stress offers the possibility for the use
in elderly patients who were not able to do exercise test-
ing.
Innovative imaging methods have been developed to
image the functional status of the heart from echocardi-
ography, magnetic resonance, PET, SPECT or CT scan
combined with electrical spatiotemporal data, making
hybrid technology ready for clinical use. In cardiology,
promising new insights are possible by demonstrating
local metabolism in acute and chronic ischemia. Electro-
cardiographic functional imaging should demonstrate
similar effects, e.g. caused by local metabolic alteration
in ischemia, but without additional contrast media or
radionuclides.
Monitoring in daily life
Future electrocardiography will integrate methods like
telemedicineandAALintodailylifetorecordandtransmit
ECGfromthehomefortheearlydetectionandprevention
of acute cardiac events. The European Union's AAL pro-
gramaddressestheneedsoftheageingEuropeanpopu-
lation by reducing innovation barriers, aimed at lowering
futuresocialsecuritycosts.Supportingself-supplyforthe
elderlywithmobilediagnosticinstrumentsforthehomes,
daily life or cars is a fascinating medical engineering
projectforthefuture.Physiologicalparametersmonitoring
should be combined with modern information technolo-
gies and supportive ambulatory care. New homecare
technologies targeting the elderly and their typical phys-
ical and mental limitations will allow them to stay home
longer. Electrocardiography will be key to ambient as-
sisted living solutions.
Closing remarks
There are promising approaches for the non-invasive
detection and risk stratification of myocardial ischemia
by enhanced electrocardiographic methods alone or in
combination with imaging technologies in patients with
suspected CAD or ACS.
Basedonouranalysisofthestateoftheartinelectrocar-
diology, we submit the following prognostic hypotheses
for the next 5 years: The standard ECG will continue to
play a major role in primary diagnostics, particularly to
detect STE infarctions in the presence of ACS symptoms.
The detection of NSTE-ACS that was previously hardly, if
all, possible by these standard methods, will be enabled
bymorerecentones,suchascardiogoniometryorBSPM.
Because of its suboptimal accuracy in relation to load
and examination time, the rank of exercise ECG for the
primary detection of stable CAD will drop. In this setting,
both imaging procedures and modern exercise-free and
shorterexaminations(e.g.cardiogoniometry)willassume
a greater role. Methods for analyzing cardiovascular
variability will become more relevant for identifying pa-
tients at-risk for life-threatening arrhythmias and for
guiding the implantation of defibrillators. HRV and BPV
based on advanced analytical methods of non-linear dy-
namics will supplement the established methods of T-
wavealternansforriskstratificationinavarietyofclinical
pictures.Inthenearfuture,functionalimagingtechniques
will remain at the research level, while their introduction
into routine diagnostics is not anticipated. Quite the op-
posite can be expected from telemedical technologies:
Inlightofthefast-pacedadvances,homecaremonitoring
will transition rapidly from the current pilot project stage
to clinical routine.
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14/19 GMS German Medical Science 2010, Vol. 8, ISSN 1612-3174
Huebner et al.: Electrocardiologic and related methods of non-invasive ...• STSD: Short-term symbolic dynamics
• UAP: Unstable angina pectoris
• VCG: Vectorcardiography
• VLP: Ventricular late potentials
• VT: Ventricular tachycardia
Notes
Conflicts of interest
ThomasHuebnerisCTOandholdsminorsharesinenver-
dis GmbH. Michael Schuepbach and Ernst Sanz hold
shares in KGMed GmbH. The other authors have nothing
to disclose.
Acknowledgments
We are much indebted to Deborah A. Landry, B.A. for her
help in preparing and editing the manuscript.
References
1. Waller AD. A demonstration on man of electromotive changes
accompanying the heart's beat. J Physiol. 1887;8(5):229-34.
2. Einthoven W. Galvanometrische registratie van het menschilijk
electrocardiogram. In: Herinneringsbundel Professor S. S.
Rosenstein. Leiden: Eduard Ijdo; 1902. p.101-7.
3. CooperJK.Electrocardiography100yearsago.Origins,pioneers
and contributors. N Engl J Med. 1986;315:461-4. DOI:
10.1056/NEJM198608143150722
4. Priori SG, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt
G,BrugadaP,CammAJ,CappatoR,CobbeSM,DiMarioC,Maron
BJ, McKenna WJ, Pedersen AK, Ravens U, Schwartz PJ, Trusz-
Gluza M, Vardas P, Wellens HJ, Zipes DP. Task Force on Sudden
Cardiac Death of the European Society of Cardiology. Eur Heart
J. 2001;22(16):1374-450. DOI: 10.1053/euhj.2001.2824
5. De Vreede-Swagemakers JJ, Gorgels AP, Dubois-Arbouw WI, van
ReeJW,DaemenMJAP,HoubenLGE,WellensHJJ.Out-of-hospital
cardiac arrest in the 1990's: a population-based study in the
Maastricht area on incidence, characteristics and survival. J Am
Coll Cardiol. 1997;30(6):1500-5. DOI: 10.1016/S0735-
1097(97)00355-0
6. ScherlagBJ,LauSH,HelfantRH,BerkowitzWD,SteinE,Damato
AN. Catheter technique for recording His bundle activity in man.
Circulation. 1969;39(1):13-8.
7. Jackman WM, Wang XZ, Friday KJ, Roman CA, Moulton KP,
Beckman KJ, McClelland JH, Twidale N, Hazlitt HA, Prior MI, et
al. Catheter ablation of accessory atrioventricular pathways
(Wolff-Parkinson-White syndrome) by radiofrequency current. N
Engl J Med. 1991;324(23):1605-11.
8. Huang DT, Monahan KM, Zimetbaum P, Papageorgiou P, Epstein
LM, Josephson ME. Hybrid pharmacologic and ablative therapy:
a novel and effective approach for the management of atrial
fibrillation. J Cardiovasc Electrophysiol. 1998;9(5):462-9.
9. Biosignalverarbeitung 2008. Workshop 16. - 18. Juli 2008,
Universität Potsdam. Frankfurt am Main: VDE Verband der
Elektrotechnik Elektronik Informationstechnik e.V.; c2006.
Available from: http://www1.vde.com/Conferences_en/
Biosignalverarbeitung2008/
10. GomezJF,ZarebaW,MossAJ,McNittS,HallWJ.Prognosticvalue
of location and type of myocardial infarction in the setting of
advanced left ventricular dysfunction. Am J Cardiol.
2007;99(5):642-6. DOI: 10.1016/j.amjcard.2006.10.021
11. Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF,
Froelicher VF, Mark DB, McCallister BD, Mooss AN, O'Reilly MG,
Winters WL, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster
V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SC;
AmericanCollegeofCardiology/AmericanHeartAssociationTask
Force on Practice Guidelines. Committee to Update the 1997
Exercise Testing Guidelines. ACC/AHA 2002 guideline update
for exercise testing: summary article. A report of the American
CollegeofCardiology/AmericanHeartAssociationTaskForceon
Practice Guidelines (Committee to Update the 1997 Exercise
TestingGuidelines).JAmCollCardiol.2002;40(8):1531-40.DOI:
10.1016/S0735-1097(02)02164-2
12. Roskamm H. Klinik der koronaren Herzkrankheit I: Angina
pectoris, stumme Myokardischämie, instabile Angina pectoris.
In: Rosskamm H, Reindell H, editors. Herzkrankheiten. 4th ed.
Berlin: Springer; 1996. p. 153-9.
13. PschyrembelKlinischesWörterbuch.261thed.Berlin,NewYork:
de Gruyter; 2007.
14. Crawford MH, Bernstein SJ, Deedwania PC, DiMarco JP, Ferrick
KJ, Garson A Jr, Green LA, Greene HL, Silka MJ, Stone PH, Tracy
CM, Gibbons RJ, Alpert JS, Eagle KA, Gardner TJ, Gregoratos G,
Russell RO, Ryan TJ, Smith SC Jr. ACC/AHA guidelines for
ambulatory electrocardiography: executive summary and
recommendations. A report of the American College of
Cardiology/American Heart Association task force on practice
guidelines (committee to revise the guidelines for ambulatory
electrocardiography). Circulation. 1999;100(8):886-93.
15. Drew BJ, Pelter MM, Lee E, Zegre J, Schindler D, Fleischmann
KE. Designing prehospital ECG systems for acute coronary
syndromes.Lessonslearnedfromclinicaltrialsinvolving12-lead
ST-segmentmonitoring.JElectrocardiol.2005;38(4Suppl):180-
5. DOI: 10.1016/j.jelectrocard.2005.06.031
16. Hamm CW. Leitlinien akutes Koronarsyndron [Guidelines: acute
coronary syndrome (ACS). 1: ACS without persistent ST segment
elevations].ZKardiol.2004;93(1):72-90.DOI:10.1007/s00392-
004-1064-2
17. Pardue WO. Arrhythmias in acute myocardial infarction: a brief
review. Am Pract Dig Treat. 1959;10(5):810-2.
18. DiamondGA,ForresterJS.Analysisofprobabilityasanaidinthe
clinical diagnosis of coronary-artery disease. N Engl J Med.
1979;300(24):1350-8.DOI:10.1056/NEJM197906143002402
19. Detrano R, Gianrossi R, Froelicher V. The diagnostic accuracy of
the exercise electrocardiogram: a meta-analysis of 22 years of
research. Prog Cardiovasc Dis. 1989;32(3):173-206. DOI:
10.1016/0033-0620(89)90025-X
20. Michaelides AP, Psomadaki ZD, Dilaveris PE, Richter DJ,
Andrikopoulos GK, Aggeli KD, Stefanadis CI, Toutouzas PK.
Improved detection of coronary artery disease by exercise
electrocardiographywiththeuseofrightprecordialleads.NEngl
J Med. 1999;340(5):340-5. DOI:
10.1056/NEJM199902043400502
21. VillellaA,MaggioniAP,VillellaM,GiordanoA,TurazzaFM,Santoro
E, Franzosi MG. Prognostic significance of maximal exercise
testing after myocardial infarction treated with thrombolytic
agents:theGISSI-2data-base.GruppoItalianoperloStudiodella
SopravvivenzaNell'Infarto.Lancet.1995;346(8974):523-9.DOI:
10.1016/S0140-6736(95)91379-3
22. Voss A, Kurths J, Kleiner HJ Witt A, Dietz R, Fiehring H, Wessel
N. High Resolution ECG Versus Heart Rate Variability - New
Results in Risk Stratification. Jap Heart J. 1994;35:331-2.
15/19 GMS German Medical Science 2010, Vol. 8, ISSN 1612-3174
Huebner et al.: Electrocardiologic and related methods of non-invasive ...23. Kuchar DL, Thorburn CW, Sammel NL. Prediction of serious
arrhythmic events after myocardial infarction: signal-averaged
electrocardiogram, Holter monitoring and radionuclide
ventriculography. J Am Coll Cardiol. 1987;9(3):531-8.
24. Santangeli P, Infusino F, Sgueglia GA, Sestito A, Lanza GA.
Ventricular late potentials: a critical overview and current
applications. J Electrocardiol. 2008;41(4):318-24. DOI:
10.1016/j.jelectrocard.2008.03.001
25. MoserDK,StevensonWG,WooMA.Optimallatepotentialcriteria
for reducing false positive signal-averaged electrocardiograms.
Am Heart J. 1992;123(2):412-6. DOI: 10.1016/0002-
8703(92)90654-E
26. Evanich MJ, Newberry AO, Partridge LD. Some limitations on the
removal of periodic noise by averaging. J Appl Physiol.
1972;33(4):536-41.
27. Medvegy M, Duray G, Pintér A, Préda I. Body surface potential
mapping:historicalbackground,presentpossibilities,diagnostic
challenges. Ann Noninvasive Electrocardiol. 2002;7(2):139-51.
DOI: 10.1111/j.1542-474X.2002.tb00155.x
28. Krenzke G, Kindt C, Hetzer R. Corrected body surface potential
mapping. Biomed Tech (Berl). 2007;52(1):37-42. DOI:
10.1515/BMT.2007.008
29. Dixit S, Callans DJ. Mapping for ventricular tachycardia. Card
Electrophysiol Rev. 2002;6(4):436-41. DOI:
10.1023/A:1021196627551
30. Lian J, Li G, Cheng J, Avitall B, He B. Body surface Laplacian
mappingofatrialdepolarizationinhealthyhumansubjects.Med
BiolEngComput.2002;40(6):650-9.DOI:10.1007/BF02345304
31. Hänninen H, Nenonen J, Mäkijärvi M, Katila T, Toivonen L.
Perspectives on body surface mapping in acute ischemic
syndromes. Intl J Bioelectromagnetism. 2003;5(1):4-6.
32. Nakajima T, Kawakubo K, Toda I, Mashima S, Ohtake T, Iio M,
Sugimoto T. ST-T isointegral analysis of exercise stress body
surface mapping for identifying ischemic areas in patients with
angina pectoris. Am Heart J. 1988;115(5):1013-21. DOI:
10.1016/0002-8703(88)90070-1
33. Hänninen H, Takala P, Mäkijärvi M, Montonen J, Korhonen P,
Oikarinen L, Simelius K, Nenonen J, Katila T, Toivonen L.
Recording locations in multichannel magnetocardiography and
body surface potential mapping sensitive for regional exercise-
inducedmyocardialischemia.BasicResCardiol.2001;96(4):405-
14. DOI: 10.1007/s003950170049
34. Lefebvre C, Hoekstra J. Early detection and diagnosis of acute
myocardial infarction: the potential for improved care with next-
generation, user-friendly electrocardiographic body surface
mapping. Am J Emerg Med. 2007;25(9):1063-72. DOI:
10.1016/j.ajem.2007.06.011
35. Burch GE. The history of vectorcardiography. Med Hist Suppl.
1985;5:103-7.
36. Wilson FN, Johnston FD. The Vectorcardiogram. Am Heart J.
1938;16(1):14-28. DOI: 10.1016/S0002-8703(38)90899-3
37. Chou TC, Helm RA, Kaplan S. Clinical Vectorcardiography. 2nd
edition. New York: Grune and Stratton; 1974.
38. Frank E. An accurate, clinically practical system for spatial
vectorcardiography. Circulation. 1956;13(5):737-49.
39. von Mengden HJ, Mayet W, Lippold K, Just H. Quantifizierung
descoronarenBefallsmustersmitHilfeeinercomputergestützten
Analyse multipler EKG-Parameter [Pattern quantification of
coronary artery stenosis by computerized analysis of multiple
ECG parameters (author's transl)]. Klin Wochenschr.
1981;59(12):629-37. DOI: 10.1007/BF02593854
40. Erikssen J, Müller C. Comparison between scalar and corrected
orthogonal electrocardiogram in diagnosis of acute myocardial
infarcts.BrHeartJ.1972;34(1):81-6.DOI:10.1136/hrt.34.1.81
41. Gray W, Corbin M, King J, Dunn M. Diagnostic value of
vectorcardiogram in strictly posterior infarction. Br Heart J.
1972;34(11):1163-9. DOI: 10.1136/hrt.34.11.1163
42. Howard PF, Benchimol A, Desser KB, Reich FD, Graves C.
Correlation of electrocardiogram and vectorcardiogram with
coronary occlusion and myocardial contraction abnormality. Am
J Cardiol. 1976;38(5):582-7. DOI: 10.1016/S0002-
9149(76)80006-9
43. McConahay DR, McCallister BD, Hallermann FJ, Smith RE.
Comparative quantitative analysis of the electrocardiogram and
thevectorcardiogram.Correlationswiththecoronaryarteriogram.
Circulation. 1970;42(2):245-59.
44. Mehta J, Hoffman I, Smedresman P, Hilsenrath J, Hamby R.
Vectorcardiographic, electrocardiographic, and angiographic
correlations in apparently isolated inferior wall myocardial
infarction. Am Heart J. 1976;91(6):699-704. DOI:
10.1016/S0002-8703(76)80534-0
45. MurrayRG,LorimerAR,DunnFG,MacfarlanePW,HuttonI,Lawrie
TD.Comparisonof12-leadandcomputer-analysed3orthogonal
lead electocardiogram in coronary artery disease. Br Heart J.
1976;38(8):773-8. DOI: 10.1136/hrt.38.8.773
46. RubulisA,JensenJ,LundahlG,TapanainenJ,WeckeL,Bergfeldt
L. T vector and loop characteristics in coronary artery disease
and during acute ischemia. Heart Rhythm. 2004;1(3):317-25.
DOI: 10.1016/j.hrthm.2004.03.076
47. RubulisA.T-vectorandT-loopmorphologyanalysisofventricular
repolarisation in ischemic heart disease. Sundbyberg: larseric
Digital Print AB; 2007.
48. Sanz E, Steger JP, Thie W. Cardiogoniometry. Clin Cardiol.
1983;6(5):199-206.
49. Schuepbach M, Emese B, Loretan P, Sanz E, Meier B. Non-
invasive diagnosis of coronary artery disease using
cardiogoniometry performed at rest. 13th World Congress on
Heart Disease, Vancouver. J Heart Dis. 2007; 5(142):A566.
50. Schüpbach WM, Emese B, Loretan P, Mallet A, Duru F, Sanz E,
MeierB.Non-invasivediagnosisofcoronaryarterydiseaseusing
cardiogoniometry performed at rest. Swiss Med Wkly.
2008;138(15-16):230-8. DOI: 2008/15/smw-12040
51. Huebner T, Schuepbach WM, Seeck A, Sanz E, Meier B, Voss A,
Pilgram R. Cardiogoniometric parameters for detection of
coronary artery disease at rest as a function of stenosis
localization and distribution. Med Biol Eng Comput.
2010;48(5):435-46. DOI: 10.1007/s11517-010-0594-1
52. Toelg R, Woelken M, Schneider S, Boksch W, Wessely R,
Birkemeyer R, Eggebrecht H, Zeymer U, Richardt G, Hamm CW
on behalf of CGM@ACS. Impact of Cardiogoniometry for early
discrimination of non-ST-segment elevation acute coronary
syndromes (NSTE-ACS) - first results of the CGM@ACS trial. Clin
ResCardiol.2010;99:Suppl1.DOI:10.1007/s00392-010-1100-
3
53. Bigger JT Jr, Albrecht P, Steinman RC, Rolnitzky LM, Fleiss JL,
Cohen RJ. Comparison of time- and frequency domain-based
measuresofcardiacparasympatheticactivityinHolterrecordings
aftermyocardialinfarction.AmJCardiol.1989;64(8):536-8.DOI:
10.1016/0002-9149(89)90436-0
54. Kleiger RE, Miller JP, Bigger JT Jr, Moss AJ. Decreased heart rate
variabilityanditsassociationwithincreasedmortalityafteracute
myocardial infarction. Am J Cardiol. 1987;59(4):256-62. DOI:
10.1016/0002-9149(87)90795-8
55. Lau S, Haueisen J, Schukat-Talamazzini EG, Voss A, Goernig M,
Leder U, Figulla HR. Low HRV entropy is strongly associated with
myocardial infarction. Biomed Tech (Berl). 2006;51(4):186-9.
DOI: 10.1515/BMT.2006.033
16/19 GMS German Medical Science 2010, Vol. 8, ISSN 1612-3174
Huebner et al.: Electrocardiologic and related methods of non-invasive ...56. Mäkikallio TH, Tapanainen JM, Tulppo MP, Huikuri HV. Clinical
applicability of heart rate variability analysis by methods based
onnonlineardynamics.CardElectrophysiolRev.2002;6(3):250-
5. DOI: 10.1023/A:1016381025759
57. VossA,KurthsJ,KleinerHJ,WittA,WesselN,SaparinP,Osterziel
KJ,SchurathR,DietzR.Theapplicationofmethodsofnon-linear
dynamicsfortheimprovedandpredictiverecognitionofpatients
threatened by sudden cardiac death. Cardiovasc Res.
1996;31(3):419-33.
58. Goernig M, Gramsch M, Baier V, Figulla HR, Leder U, Voss A.
Altered autonomic cardiac control predicts restenosis after
percutaneous coronary intervention. Pacing Clin Electrophysiol.
2006;29(2):188-91.DOI:10.1111/j.1540-8159.2006.00315.x
59. Task Force of the European Society of Cardiology and the North
American Society of Pacing and Electrophysiology. Heart rate
variability. Standards of measurement, physiological
interpretation,andclinicaluse.EurHeartJ.1996;17(3):354-81.
60. TsujiH,LarsonMG,VendittiFJJr,MandersES,EvansJC,Feldman
CL, Levy D. Impact of reduced heart rate variability on risk for
cardiac events. The Framingham Heart Study. Circulation.
1996;94(11):2850-5.
61. LiaoD,CaiJ,RosamondWD,BarnesRW,HutchinsonRG,Whitsel
EA, Rautaharju P, Heiss G. Cardiac autonomic function and
incidentcoronaryheartdisease:apopulation-basedcase-cohort
study. The ARIC Study. Atherosclerosis Risk in Communities
Study. Am J Epidemiol. 1997;145(8):696-706.
62. Bigger JT, Fleiss JL, Rolnitzky LM, Steinman RC. The ability of
severalshort-termmeasuresofRRvariabilitytopredictmortality
after myocardial infarction. Circulation. 1993;88(3):927-34.
63. Bigger JT Jr, Steinman RC, Rolnitzky LM, Fleiss JL, Albrecht P,
CohenRJ.PowerlawbahaviorofRR-intervalvariabilityinhealthy
middle-aged persons, patients with recent acute myocardial
infarction, and patients with heart transplants. Circulation.
1996;93(12):2142-51.
64. Voss A, Hnatkova K, Wessel N, Kurths J, Sander A, Schirdewan
A, Camm AJ, Malik M. Multiparametric analysis of heart rate
variability used for risk stratification among survivors of acute
myocardial infarction. Pacing Clin Electrophysiol. 1998;21(1 Pt
2):186-92. DOI: 10.1111/j.1540-8159.1998.tb01086.x
65. Mäkikallio TH, Høiber S, Køber L, Torp-Pedersen C, Peng CK,
GoldbergerAL,HuikuriHV.Fractalanalysisofheartratedynamics
as a predictor of mortality in patients with depressed left
ventricular function after acute myocardial infarction. TRACE
Investigators. TRAndolapril Cardiac Evaluation. Am J Cardiol.
1999;83(6):836-9. DOI: 10.1016/S0002-9149(98)01076-5
66. Huikuri HV, Mäkikallio TH, Peng CK, Goldberger AL, Hintze U,
Møller M. Fractal correlation properties of R-R interval dynamics
andmortalityinpatientswithdepressedleftventricularfunction
afteranacutemyocardialinfarction.Circulation.2000;101(1):47-
53.
67. Jokinen V, Tapanainen JM, Seppänen T, Huikuri HV. Temporal
changes and prognostic significance of measures of heart rate
dynamics after acute myocardial infarction in the beta-blocking
era. Am J Cardiol. 2003;92(8):907-12. DOI: 10.1016/S0002-
9149(03)00968-8
68. Mäkikallio TH, Huikuri HV, Hintze U, Videbaek J, Mitrani RD,
Castellanos A, Myerburg RJ, Møller M; DIAMOND Study Group
(DanishInvestigationsofArrhythmiaandMortalityONDofetilide).
Fractal analysis and time- and frequency-domain measures of
heart rate variability as predictors of mortality in patients with
heart failure. Am J Cardiol. 2001;87(2):178-82. DOI:
10.1016/S0002-9149(00)01312-6
69. Schmidt G, Malik M, Barthel P, Schneider R, Ulm K, Rolnitzky L,
Camm AJ, Bigger JT Jr, Schömig A. Heart-rate turbulence after
ventricularprematurebeatsasapredictorofmortalityafteracute
myocardial infarction. Lancet. 1999;353(9162):1390-6. DOI:
10.1016/S0140-6736(98)08428-1
70. Parati G, Di Rienzo M, Bertinieri G, Pomidossi G, Casadei R,
Groppelli A, Pedotti A, Zanchetti A, Mancia G. Evaluation of the
baroreceptor-heart rate reflex by 24-hour intra-arterial blood
pressuremonitoringinhumans.Hypertension.1988;12(2):214-
22.
71. Pompe B, Blidh P, Hoyer D, Eiselt M. Using mutual information
to measure coupling in the cardiorespiratory system. IEEE Eng
Med Biol Mag. 1998;17(6):32-9. DOI: 10.1109/51.731318
72. Schäfer C, Rosenblum MG, Kurths J, Abel HH. Heartbeat
synchronizedwithventilation.Nature.1998;392(6673):239-40.
DOI: 10.1038/32567
73. Baumert M, Walther T, Hopfe J, Stepan H, Faber R, Voss A. Joint
symbolic dynamic analysis of beat-to-beat interactions of heart
rate and systolic blood pressure in normal pregnancy. Med Biol
Eng Comput. 2002;40(2):241-5. DOI: 10.1007/BF02348131
74. Schwab K, Eiselt M, Putsche P, Helbig M, Witte H. Time-variant
parametric estimation of transient quadratic phase couplings
between heart rate components in healthy neonates. Med Biol
Eng Comput. 2006;44(12):1077-83. DOI: 10.1007/s11517-
006-0120-7
75. Van Leeuwen P, Geue D, Thiel M, Cysarz D, Lange S, Romano
MC, Wessel N, Kurths J, Grönemeyer DH. Influence of paced
maternal breathing on fetal-maternal heart rate coordination.
Proc Natl Acad Sci U S A. 2009;106(33):13661-6. DOI:
10.1073/pnas.0901049106
76. Werdan K, Schmidt H, Ebelt H, Zorn-Pauly K, Koidl B, Hoke RS,
Heinroth K, Müller-Werdan U. Impaired regulation of cardiac
function in sepsis, SIRS, and MODS. Can J Physiol Pharmacol.
2009;87(4):266-74. DOI: 10.1139/Y09-012
77. Goldberger AL. Is the normal heartbeat chaotic or homeostatic?
News Physiol Sci. 1991;6:87-91.
78. Colosimo A, Giuliani A, Mancini AM, Piccirillo G, Marigliano V.
Estimating a cardiac age by means of heart rate variability. Am
J Physiol. 1997 Oct;273(4 Pt 2):H1841-7.
79. RyanSM,GoldbergerAL,PincusSM,MietusJ,LipsitzLA.Gender-
and age-related differences in heart rate dynamics: are women
more complex than men? J Am Coll Cardiol. 1994;24(7):1700-
7. DOI: 10.1016/0735-1097(94)90177-5
80. StaussHM.Identificationofbloodpressurecontrolmechanisms
by power spectral analysis. Clin Exp Pharmacol Physiol.
2007;34(4):362-8. DOI: 10.1111/j.1440-1681.2007.04588.x
81. Malberg H, Wessel N, Hasart A, Osterziel KJ, Voss A. Advanced
analysis of spontaneous baroreflex sensitivity, blood pressure
andheartratevariabilityinpatientswithdilatedcardiomyopathy.
Clin Sci (Lond). 2002;102(4):465-73. DOI:
10.1042/CS20010106
82. StaussHM.Identificationofbloodpressurecontrolmechanisms
by power spectral analysis. Clin Exp Pharmacol Physiol.
2007;34(4):362-8. DOI: 10.1111/j.1440-1681.2007.04588.x
83. Voss A, Schroeder R, Truebner S, Goernig M, Figulla HR,
Schirdewan A. Comparison of nonlinear methods symbolic
dynamics, detrended fluctuation, and Poincare plot analysis in
riskstratificationinpatientswithdilatedcardiomyopathy.Chaos.
2007;17(1):015120. DOI: 10.1063/1.2404633
84. Bloomfield DM, Bigger JT, Steinman RC, Namerow PB, Parides
MK, Curtis AB, Kaufman ES, Davidenko JM, Shinn TS, Fontaine
JM.MicrovoltT-wavealternansandtheriskofdeathorsustained
ventricular arrhythmias in patients with left ventricular
dysfunction. J Am Coll Cardiol. 2006;47(2):456-63. DOI:
10.1016/j.jacc.2005.11.026
17/19 GMS German Medical Science 2010, Vol. 8, ISSN 1612-3174
Huebner et al.: Electrocardiologic and related methods of non-invasive ...85. Gehi AK, Stein RH, Metz LD, Gomes JA. Microvolt T-wave
alternansfortheriskstratificationofventriculartachyarrhythmic
events: a meta-analysis. J Am Coll Cardiol. 2005;46(1):75-82.
DOI: 10.1016/j.jacc.2005.03.059
86. Exner DV, Kavanagh KM, Slawnych MP, Mitchell LB, Ramadan
D, Aggarwal SG, Noullett C, Van Schaik A, Mitchell RT, Shibata
MA, Gulamhussein S, McMeekin J, Tymchak W, Schnell G, Gillis
AM, Sheldon RS, Fick GH, Duff HJ; REFINE Investigators.
Noninvasive risk assessment early after a myocardial infarction
the REFINE study. J Am Coll Cardiol. 2007;50(24):2275-84.
87. CostantiniO,HohnloserSH,KirkMM,LermanBB,BakerJH2nd,
Sethuraman B, Dettmer MM, Rosenbaum DS; ABCD Trial
Investigators. The ABCD (Alternans Before Cardioverter
Defibrillator) Trial: strategies using T-wave alternans to improve
efficiency of sudden cardiac death prevention. J Am Coll Cardiol.
2009;53(6):471-9. DOI: 10.1016/j.jacc.2008.08.077
88. Dossel O, Bauer W, Farina D, Kaltwasser C, Skipa O. Imaging of
bioelectricsourcesintheheartusingacellularautomatonmodel.
Conf Proc IEEE Eng Med Biol Soc. 2005;2:1067-70. DOI:
10.1109/IEMBS.2005.1616603
89. He B, Wu D. Imaging and visualization of 3-D cardiac electric
activity. IEEE Trans Inf Technol Biomed. 2001;5(3):181-6. DOI:
10.1109/4233.945288
90. Cleland JG, Louis AA, Rigby AS, Janssens U, Balk AH; TEN-HMS
Investigators.Noninvasivehometelemonitoringforpatientswith
heart failure at high risk of recurrent admission and death: the
Trans-EuropeanNetwork-Home-CareManagementSystem(TEN-
HMS) study. J Am Coll Cardiol. 2005;45(10):1654-64. DOI:
10.1016/j.jacc.2005.01.050
91. Bauer S, Baumann M, Becks T, et al. VDE-recomondations for
TeleMonitoring.QualitymanagementISO9001:2005.Frankfurt:
VDE e.V.; 2006.
92. OrtolaniP,MarzocchiA,MarrozziniC,PalmeriniT,SaiaF,Baldazzi
F,SilenziS,TaglieriN,Bacchi-ReggianiML,GordiniG,Guastaroba
P, Grilli R, Branzi A. Usefulness of prehospital triage in patients
with cardiogenic shock complicating ST-elevation myocardial
infarction treated with primary percutaneous coronary
intervention. Am J Cardiol. 2007;100(5):787-92. DOI:
10.1016/j.amjcard.2007.03.099
93. Goernig,M,Doede,T,Brehm,B,Figulla,HR,Leder,U.Ambulatory
Disease Management in Cardiac Patients: 12 month follow-up
of Home Care Telemedicine in Thuringia by the Management
Program Zertiva®. Phys Med Rehab. 2009;19(1):9-13. DOI:
10.1055/s-0028-1112113
94. AmbientAssistedLivingJointProgramme[Homepage].Brussels:
AmbientAssistedLivingAssociation;2010.Availablefrom:http://
www.aal-europe.eu/about-aal
95. Boulos MN, Rocha A, Martins A, Vicente ME, Bolz A, Feld R,
Tchoudovski I, Braecklein M, Nelson J, Laighin GO, Sdogati C,
Cesaroni F, Antomarini M, Jobes A, Kinirons M. CAALYX: a new
generation of location-based services in healthcare. Int J Health
Geogr. 2007;6:9. DOI: 10.1186/1476-072X-6-9
96. Mazzù M, Scalvini S, Giordano A, Frumento E, Wells H, Lokhorst
K, Glisenti F. Wireless-accessible sensor populations for
monitoring biological variables. J Telemed Telecare.
2008;14(3):135-7. DOI: 10.1258/jtt.2008.003010
97. Brignell M, Wootton R, Gray L. The application of telemedicine
to geriatric medicine. Age Ageing. 2007;36(4):369-74. DOI:
10.1093/ageing/afm045
98. Valdastri P, Menciassi A, Arena A, Caccamo C, Dario P. An
implantable telemetry platform system for in vivo monitoring of
physiological parameters. IEEE Trans Inf Technol Biomed.
2004;8(3):271-8. DOI: 10.1109/TITB.2004.834389
99. Schurr MO. Microsystems in medicine, Official report of the
netmed project (g7rt-ct-2002-05113), funded by the European
union. Berlin: IHCI, Steinbeis University; 2005.
100. DeBacquerD,DeBackerG,KornitzerM,BlackburnH.Prognostic
value of ECG findings for total, cardiovascular disease, and
coronary heart disease death in men and women. Heart.
1998;80(6):570-7.
101. Mazzadi AN, André-Fouët X, Costes N, Croisille P, Revel D, Janier
MF. Mechanisms leading to reversible mechanical dysfunction
in severe CAD: alternatives to myocardial stunning. Am J Physiol
Heart Circ Physiol. 2006;291(6):H2570-82. DOI:
10.1152/ajpheart.01249.2005
102. Bryant J, Brodin H, Loveman E, Clegg A. Clinical effectiveness
and cost-effectiveness of implantable cardioverter defibrillators
for arrhythmias: a systematic review and economic evaluation.
Int J Technol Assess Health Care. 2007;23(1):63-70. DOI:
10.1017/S0266462307051586
103. Voss A, Schulz S, Schroeder R, Baumert M, Caminal P. Methods
derived from nonlinear dynamics for analysing heart rate
variability. Philos Transact A Math Phys Eng Sci.
2009;367(1887):277-96. DOI: 10.1098/rsta.2008.0232
104. CeruttiS,HoyerD,VossA.Multiscale,multiorganandmultivariate
complexityanalysesofcardiovascularregulation.PhilosTransact
A Math Phys Eng Sci. 2009;367(1892):1337-58. DOI:
10.1098/rsta.2008.0267
105. Cain ME, Ambos HD, Witkowski FX, Sobel BE. Fast-Fourier
transform analysis of signal-averaged electrocardiograms for
identification of patients prone to sustained ventricular
tachycardia. Circulation. 1984;69(4):711-20.
106. Breithardt G, Borggrefe M. Recent advances in the identification
of patients at risk of ventricular tachyarrhythmias: role of
ventricular late potentials. Circulation. 1987;75(6):1091-6.
107. SimsonMB.UseofsignalsintheterminalQRScomplextoidentify
patients with ventricular tachycardia after myocardial infarction.
Circulation. 1981;64(2):235-42.
108. WajszczukWJ,StopczykMJ,MoskowitzMS,ZochowskiRJ,Bauld
T, Dabos PL, Rubenfire M. Noninvasive recording of His-Purkinje
activity in man by ORS-triggered signal averaging. Circulation.
1978;58(1):95-102.
109. Fontaine G, Frank R, Gallais-Hamonno F, Allali I, Phan-Thuc H,
Grosgogeat Y. Electrocardiographie des potentiels tardifs du
syndrome de post-excitation [Electrocardiography of delayed
potentials in post-excitation syndrome]. Arch Mal Coeur Vaiss.
1978;71(8):854-64.
Corresponding author:
Thomas Huebner, M.Sc.
University for Health Sciences, Medical Informatics and
Technology(UMIT),DepartmentforHumanandEconomic
Sciences, Eduard-Wallnoefer-Zentrum 1, A-6060 Hall,
Austria, T: +49 (0) 171 - 69 852 73, Fax: +49 (0) 36 41-
53 49 019
thomas.huebner@umit.at
Please cite as
Huebner T, Goernig M, Schuepbach M, Sanz E, Pilgram R, Seeck A,
VossA.Electrocardiologicandrelatedmethodsofnon-invasivedetection
and risk stratification in myocardial ischemia: state of the art and
perspectives. GMS Ger Med Sci. 2010;8:Doc27.
DOI: 10.3205/000116, URN: urn:nbn:de:0183-0001164
This article is freely available from
http://www.egms.de/en/journals/gms/2010-8/000116.shtml
18/19 GMS German Medical Science 2010, Vol. 8, ISSN 1612-3174
Huebner et al.: Electrocardiologic and related methods of non-invasive ...Received: 2010-05-01
Revised: 2010-08-26
Published: 2010-10-11
Copyright
©2010 Huebner et al. This is an Open Access article distributed under
the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en). You
are free: to Share — to copy, distribute and transmit the work, provided
the original author and source are credited.
19/19 GMS German Medical Science 2010, Vol. 8, ISSN 1612-3174
Huebner et al.: Electrocardiologic and related methods of non-invasive ...